These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 8099482

  • 1. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL, Callaway CW, Geyer MA.
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [Abstract] [Full Text] [Related]

  • 2. Subthalamic 5-HT(1A) and 5-HT(1B) receptor modulation of RU 24969-induced behavioral profile in rats.
    Martinez-Price DL, Geyer MA.
    Pharmacol Biochem Behav; 2002 Apr; 71(4):569-80. PubMed ID: 11888548
    [Abstract] [Full Text] [Related]

  • 3. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    Callaway CW, Geyer MA.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158
    [Abstract] [Full Text] [Related]

  • 4. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 5. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA.
    Psychopharmacology (Berl); 1991 Aug; 104(3):293-301. PubMed ID: 1924637
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC, Bankson MG, Cunningham KA.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [Abstract] [Full Text] [Related]

  • 7. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW, Rempel N, Peng RY, Geyer MA.
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [Abstract] [Full Text] [Related]

  • 8. Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.
    Aronsen D, Bukholt N, Schenk S.
    Psychopharmacology (Berl); 2016 Apr; 233(8):1339-47. PubMed ID: 26856853
    [Abstract] [Full Text] [Related]

  • 9. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats.
    Krebs KM, Geyer MA.
    Psychopharmacology (Berl); 1993 Apr; 113(2):284-7. PubMed ID: 7855195
    [Abstract] [Full Text] [Related]

  • 10. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
    Fletcher PJ, Sinyard J, Higgins GA.
    Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
    [Abstract] [Full Text] [Related]

  • 11. MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.
    Aronsen D, Schenk S.
    Psychopharmacology (Berl); 2016 Apr; 233(7):1323-30. PubMed ID: 26856854
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic functions in arousal and motor activity.
    Geyer MA.
    Behav Brain Res; 1996 Apr; 73(1-2):31-5. PubMed ID: 8788473
    [Abstract] [Full Text] [Related]

  • 13. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat.
    Chaouloff F, Courvoisier H, Moisan MP, Mormède P.
    Psychopharmacology (Berl); 1999 Jan; 141(3):326-31. PubMed ID: 10027515
    [Abstract] [Full Text] [Related]

  • 14. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.
    Halberstadt AL, Buell MR, Price DL, Geyer MA.
    Pharmacol Biochem Behav; 2012 Jul; 102(1):88-94. PubMed ID: 22487771
    [Abstract] [Full Text] [Related]

  • 15. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
    Fletcher PJ, Korth KM, Robinson SR, Baker GB.
    Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
    [Abstract] [Full Text] [Related]

  • 16. Serotonin 5-HT1A and 5-HT1B receptors co-mediate the RU 24969-induced locomotor activity of male and female preweanling rats.
    McDougall SA, Robinson JAM, Ramirez EL, Diaz HA.
    Pharmacol Biochem Behav; 2020 Feb; 189():172857. PubMed ID: 31958472
    [Abstract] [Full Text] [Related]

  • 17. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
    Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH.
    Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
    [Abstract] [Full Text] [Related]

  • 18. RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
    Fletcher PJ, Korth KM.
    Behav Pharmacol; 1999 Mar; 10(2):183-93. PubMed ID: 10780831
    [Abstract] [Full Text] [Related]

  • 19. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ, Yamamoto BK.
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [Abstract] [Full Text] [Related]

  • 20. Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor.
    Scearce-Levie K, Viswanathan SS, Hen R.
    Psychopharmacology (Berl); 1999 Jan; 141(2):154-61. PubMed ID: 9952039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.